Safety of Onasemnogene Abeparvovec for Patients With Spinal Muscular Atrophy 8.5 kg or Heavier in a Global Managed Access Program

  • Deepa H. Chand
  • , Susan Mitchell
  • , Rui Sun
  • , Nicole LaMarca
  • , Sandra P. Reyna
  • , Thao Sutter

Research output: Contribution to journal › Article › peer-review

25   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Safety of Onasemnogene Abeparvovec for Patients With Spinal Muscular Atrophy 8.5 kg or Heavier in a Global Managed Access Program'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science